A case of refractory anti-MDA5-positive amyopathic dermatomyositis successfully treated with upadacitinib

A case of refractory anti-MDA5-positive amyopathic dermatomyositis successfully treated with upadacitinib

Purpose: Amyopathic dermatomyositis (ADM) is a rare, idiopathic, connective tissue disease and melanoma differentiation-associated protein 5 (MDA5) antibody-positive ADM is more treatment-resistant, especially in patients with interstitial lung disease (ILD). The purpose of this article is to report...

Full description

Bibliographic Details
Main Authors: Xin Huang, Guiying Zhang, Shuaihantian Luo
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Journal of Dermatological Treatment
Subjects:
Amyopathic dermatomyositis
melanoma differentiation-associated protein 5
upadacitinib
treatment
Online Access:https://www.tandfonline.com/doi/10.1080/09546634.2024.2391445

Internet

https://www.tandfonline.com/doi/10.1080/09546634.2024.2391445

Similar Items